Cargando…
Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.S.
OBJECTIVE: A recent publication questioned the integrity of insulin purchased from U.S. retail pharmacies. We sought to independently validate the method used, isotope dilution solid-phase extraction (SPE) liquid chromatography mass spectrometry (LC-MS), and expand analysis to two U.S. Pharmacopeia...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245346/ https://www.ncbi.nlm.nih.gov/pubmed/32273273 http://dx.doi.org/10.2337/dc19-1941 |
_version_ | 1783537739885445120 |
---|---|
author | Garrett, Timothy J. Atkinson, Philip Quinlivan, Eoin P. Ang, Lynn Hirsch, Irl B. Laffel, Lori Pietropaolo, Massimo Haller, Michael J. Atkinson, Mark A. |
author_facet | Garrett, Timothy J. Atkinson, Philip Quinlivan, Eoin P. Ang, Lynn Hirsch, Irl B. Laffel, Lori Pietropaolo, Massimo Haller, Michael J. Atkinson, Mark A. |
author_sort | Garrett, Timothy J. |
collection | PubMed |
description | OBJECTIVE: A recent publication questioned the integrity of insulin purchased from U.S. retail pharmacies. We sought to independently validate the method used, isotope dilution solid-phase extraction (SPE) liquid chromatography mass spectrometry (LC-MS), and expand analysis to two U.S. Pharmacopeia (USP) methods (high-performance LC with ultraviolet detection and LC-MS). RESEARCH DESIGN AND METHODS: Each method was used to evaluate nine insulin formulations, purchased at four pharmacies, within five geographic locations in the U.S. RESULTS: All human and analog insulins measured by the USP methods (n = 174) contained the expected quantity of active insulin (100 ± 5 units/mL). When using isotope dilution SPE-LC-MS, units-per-milliliter values were well below product labeling due to unequal recovery of the internal standard compared with target insulin. CONCLUSIONS: Insulin purchased from U.S. pharmacies is consistent with product labeling. |
format | Online Article Text |
id | pubmed-7245346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-72453462020-06-03 Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.S. Garrett, Timothy J. Atkinson, Philip Quinlivan, Eoin P. Ang, Lynn Hirsch, Irl B. Laffel, Lori Pietropaolo, Massimo Haller, Michael J. Atkinson, Mark A. Diabetes Care Novel Communications in Diabetes OBJECTIVE: A recent publication questioned the integrity of insulin purchased from U.S. retail pharmacies. We sought to independently validate the method used, isotope dilution solid-phase extraction (SPE) liquid chromatography mass spectrometry (LC-MS), and expand analysis to two U.S. Pharmacopeia (USP) methods (high-performance LC with ultraviolet detection and LC-MS). RESEARCH DESIGN AND METHODS: Each method was used to evaluate nine insulin formulations, purchased at four pharmacies, within five geographic locations in the U.S. RESULTS: All human and analog insulins measured by the USP methods (n = 174) contained the expected quantity of active insulin (100 ± 5 units/mL). When using isotope dilution SPE-LC-MS, units-per-milliliter values were well below product labeling due to unequal recovery of the internal standard compared with target insulin. CONCLUSIONS: Insulin purchased from U.S. pharmacies is consistent with product labeling. American Diabetes Association 2020-06 2020-04-09 /pmc/articles/PMC7245346/ /pubmed/32273273 http://dx.doi.org/10.2337/dc19-1941 Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
spellingShingle | Novel Communications in Diabetes Garrett, Timothy J. Atkinson, Philip Quinlivan, Eoin P. Ang, Lynn Hirsch, Irl B. Laffel, Lori Pietropaolo, Massimo Haller, Michael J. Atkinson, Mark A. Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.S. |
title | Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.S. |
title_full | Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.S. |
title_fullStr | Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.S. |
title_full_unstemmed | Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.S. |
title_short | Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.S. |
title_sort | commercially available insulin products demonstrate stability throughout the cold supply chain across the u.s. |
topic | Novel Communications in Diabetes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245346/ https://www.ncbi.nlm.nih.gov/pubmed/32273273 http://dx.doi.org/10.2337/dc19-1941 |
work_keys_str_mv | AT garretttimothyj commerciallyavailableinsulinproductsdemonstratestabilitythroughoutthecoldsupplychainacrosstheus AT atkinsonphilip commerciallyavailableinsulinproductsdemonstratestabilitythroughoutthecoldsupplychainacrosstheus AT quinlivaneoinp commerciallyavailableinsulinproductsdemonstratestabilitythroughoutthecoldsupplychainacrosstheus AT anglynn commerciallyavailableinsulinproductsdemonstratestabilitythroughoutthecoldsupplychainacrosstheus AT hirschirlb commerciallyavailableinsulinproductsdemonstratestabilitythroughoutthecoldsupplychainacrosstheus AT laffellori commerciallyavailableinsulinproductsdemonstratestabilitythroughoutthecoldsupplychainacrosstheus AT pietropaolomassimo commerciallyavailableinsulinproductsdemonstratestabilitythroughoutthecoldsupplychainacrosstheus AT hallermichaelj commerciallyavailableinsulinproductsdemonstratestabilitythroughoutthecoldsupplychainacrosstheus AT atkinsonmarka commerciallyavailableinsulinproductsdemonstratestabilitythroughoutthecoldsupplychainacrosstheus |